Takeda India Strengthens Patient Offering via Availability of Vedolizumab

Introduces innovative Gastrointestinal portfolio for patients with Inflammatory Bowel Diseases (IBD) and Ulcerative Colitis and Crohn’s Disease. Takeda India, part of the Takeda Pharmaceutical Company Ltd., a global values-based…

Read More Takeda India Strengthens Patient Offering via Availability of Vedolizumab

India Now Has the World’s Second Largest Population with Inflammatory Bowel Disease (IBD)

On May 19, the World IBD Day, leading Indian gastroenterologists come together for IBD Awareness Campaign #ManageYourIBD to complement the global movement around #MakeIBDWork. Wellness…

Read More India Now Has the World’s Second Largest Population with Inflammatory Bowel Disease (IBD)
Top